Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
66,543,505
-
Share change
-
+1,932,077
-
Total reported value
-
$4,204,958,379
-
Put/Call ratio
-
274%
-
Price per share
-
$63.19
-
Number of holders
-
225
-
Value change
-
+$136,584,141
-
Number of buys
-
125
-
Number of sells
-
105
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2025
As of 30 Jun 2025,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,543,505 shares.
The largest 10 holders included
BlackRock, Inc., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This page lists
225
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.